跳至主要内容
临床试验/NCT00883415
NCT00883415已完成不适用

A Study to Evaluate the Effect of the Treatment of Anemia on Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney Disease

University of Maryland, Baltimore1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2008年5月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Change to Myocardial Glucose Uptake as Measured by Fluoro-deoxy-D-glucose (FDG) Positron Emission Tomography (PET) Scan From Pre-treatment Compared to 6 Months After Anemia Therapy Initiation.

研究概览

简要总结

This study examines patients with chronic kidney disease-related anemia and measures changes in the metabolism of the heart using FDG/PET scanning, before and 6 months after their health-care provider has initiated anemia management therapy with the FDA-approved drug darbepoetin alfa (Aranesp), which is approved for chronic kidney disease-related anemia. The investigators hypothesize that the heart has abnormal metabolism with the anemia of chronic kidney disease but this improves after correction of this anemia with darbepoetin alfa.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant must receive care at the VAMHCS (VA Hospital) in Baltimore
  • Diagnosed with CKD stage 3 to 5 (eGFR of 60 ml/min/1.73m2) and not expected to initiate renal replacement therapy within 6 months
  • Anemia related CKD.
  • The last 2 serum hemoglobin (Hb) values less than 11.0 gm/dl but greater than 8.0 gm/dl
  • Greater than 18 years of age
  • Assessed to be clinically stable by the clinician

排除标准

  • Need for hemodialysis, peritoneal dialysis, or transplantation at the time of enrollment or projected to start within 6 months after enrollment
  • Low functional capacity including inability to walk a flight of stairs with a bag of groceries (NYHA Class III/IV Heart Failure)
  • Prior erythropoietic agents within last 12 weeks
  • TSAT < 15% and not receiving the recommended dose for iron deficiency
  • Uncontrolled hypertension defined as greater than 180 mm Hg systolic or 110 mm Hg diastolic
  • Potentially "brittle" diabetes with the propensity for symptomatic hypoglycemia after a 6 hour fast
  • New diagnosis or ongoing therapy for Cancer
  • Pregnancy

结局指标

主要结局

Change to Myocardial Glucose Uptake as Measured by Fluoro-deoxy-D-glucose (FDG) Positron Emission Tomography (PET) Scan From Pre-treatment Compared to 6 Months After Anemia Therapy Initiation.

时间窗: 6 months

Change in myocardial glucose uptake from baseline to 6 months expressed as change in micromol/min/100 g

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeffrey Fink

Professor, Nephrology (primary); Epidemiology (secondary)

University of Maryland, Baltimore

研究点 (1)

Loading locations...

相似试验